SAR447537 clinical trials

Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema

This study looks at a new long-term treatment called SAR447537 for adults with lung damage (emphysema) caused by a condition called Alpha-1 Antitrypsin Deficiency (AATD). It will check how safe and effective this treatment is over time.